Med-Chemist : "Quintessential Medicinal Chemistry"
Thursday, May 19, 2016
Novartis announces FDA approval of Afinitor for progressive, nonfunctional neuroendocrine tumors of GI
›
In continuation of my update on Everolimus Novartis today announced that the United States Food and Drug Administration (FD...
Wednesday, May 18, 2016
New drug shows promise against Huntington's disease
›
A drug that would be the first to target the cause of Huntington's disease (HD) is effective and safe when tested in mice and monkeys,...
Tuesday, May 17, 2016
PCSK9-inhibitor drugs: A game-changer for individuals with extremely high cholesterol levels
›
A 59-year-old heart patient with dangerously high levels of cholesterol that could not be adequately reduced by statin drugs now has near-...
Monday, May 16, 2016
Steroid May Be Safe, Effective Gout Treatment, Study Finds
›
A steroid pill may be as good as a nonsteroidal anti-inflammatory drug (NSAID) for treating painful gout, new research suggests. Resea...
2 comments:
Friday, May 13, 2016
New molecule has potential to prolong life of cystic fibrosis patients
›
New molecule has potential to prolong life of cystic fibrosis patients : Scientists at Queen's University Belfast have discovered a new ...
Pfizer Receives Expanded FDA Approval For Ibrance (palbociclib) In HR , HER2- Metastatic Breast Cancer
›
In continuation of my updates on palbociclib Pfizer Inc. (NYSE:PFE) announced that the U.S. Food and Drug Administration (FDA) h...
Thursday, May 12, 2016
FDA Approves Briviact (brivaracetam) to Treat Partial Onset Seizures
›
The U.S. Food and Drug Administration yesterday approved Briviact (brivaracetam) as an add-on treatment to other medications to treat ...
Wednesday, May 11, 2016
Pfizer Receives Expanded FDA Approval For Ibrance (palbociclib) In HR , HER2- Metastatic Breast Cancer
›
In continuation of my updates on palbociclib Pfizer Inc. (NYSE:PFE) announced that the U.S. Food and Drug Administration (FDA) h...
Tuesday, May 10, 2016
FDA-approved Alzheimer's medications may help people quit smoking
›
Despite several safe drug therapies available to help smokers quit, three-quarters report relapsing within six months of a quit attempt. U...
Monday, May 9, 2016
No evidence found linking anti-nausea drug to birth defects
›
No evidence found linking anti-nausea drug to birth defects : No evidence has been found to link the anti-nausea drug Zofran to an increas...
Novartis receives FDA Breakthrough Therapy designation for PKC412 (midostaurin)
›
Novartis announced today that the United States Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to PKC...
Friday, May 6, 2016
Lenalidomide trials show potential for expanding lymphoma, leukaemia indications
›
Positive findings from two clinical trials have been published for the immunomodulatory agent lenalidomide in patients with heavily pr...
1 comment:
Tuesday, May 3, 2016
FDA Approves Zepatier (elbasvir and grazoprevir) for Chronic Hepatitis C Genotypes 1 and 4
›
(Elbasvir) (Grazoprevir) The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or w...
Monday, May 2, 2016
FDA Approves Expanded Use of Daklinza (daclatasvir) for Additional Challenging-to-treat Patients with Genotype 1 or Genotype 3 Chronic Hepatitis C
›
In continuation of my update on daclatasvir Bristol-Myers Squibb Company (NYSE:BMY) announced today that Daklinza (daclatasvi...
St. Renatus, LLC Announces FDA Approval of Kovanaze (tetracaine HCl and oxymetazoline HCl) Nasal Spray for Use in Dentistry
›
St. Renatus, LLC, a privately held company based in Fort Collins, Colorado, announced the U.S. Food and Drug Administration (FDA) approva...
‹
›
Home
View web version